Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Cannabinoid Ligands Targeting TRP Channels.

Muller C, Morales P, Reggio PH.

Front Mol Neurosci. 2019 Jan 15;11:487. doi: 10.3389/fnmol.2018.00487. eCollection 2018. Review.

2.

Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma.

Vuolo F, Abreu SC, Michels M, Xisto DG, Blanco NG, Hallak JE, Zuardi AW, Crippa JA, Reis C, Bahl M, Pizzichinni E, Maurici R, Pizzichinni MMM, Rocco PRM, Dal-Pizzol F.

Eur J Pharmacol. 2019 Jan 15;843:251-259. doi: 10.1016/j.ejphar.2018.11.029. Epub 2018 Nov 24.

PMID:
30481497
3.

Neuroprotection by cannabidiol and hypothermia in a piglet model of newborn hypoxic-ischemic brain damage.

Barata L, Arruza L, Rodríguez MJ, Aleo E, Vierge E, Criado E, Sobrino E, Vargas C, Ceprián M, Gutiérrez-Rodríguez A, Hind W, Martínez-Orgado J.

Neuropharmacology. 2019 Mar 1;146:1-11. doi: 10.1016/j.neuropharm.2018.11.020. Epub 2018 Nov 20.

PMID:
30468796
4.

Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.

Abdallah SJ, Smith BM, Ware MA, Moore M, Li PZ, Bourbeau J, Jensen D.

Ann Am Thorac Soc. 2018 Oct;15(10):1146-1158. doi: 10.1513/AnnalsATS.201803-198OC.

PMID:
30049223
5.

Cannabidiol induced apoptosis in human monocytes through mitochondrial permeability transition pore-mediated ROS production.

Wu HY, Huang CH, Lin YH, Wang CC, Jan TR.

Free Radic Biol Med. 2018 Aug 20;124:311-318. doi: 10.1016/j.freeradbiomed.2018.06.023. Epub 2018 Jun 22.

PMID:
29940353
6.

[Cannabis and lung. What we know and everything we don't know yet].

Urban T, Hureaux J.

Rev Pneumol Clin. 2017 Dec;73(6):283-289. doi: 10.1016/j.pneumo.2017.08.013. Epub 2017 Nov 8. Review. French.

PMID:
29126755
7.

Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury.

Wang Y, Mukhopadhyay P, Cao Z, Wang H, Feng D, Haskó G, Mechoulam R, Gao B, Pacher P.

Sci Rep. 2017 Sep 21;7(1):12064. doi: 10.1038/s41598-017-10924-8.

8.

Effects of antiepileptic drugs on mitochondrial functions, morphology, kinetics, biogenesis, and survival.

Finsterer J, Scorza FA.

Epilepsy Res. 2017 Oct;136:5-11. doi: 10.1016/j.eplepsyres.2017.07.003. Epub 2017 Jul 13. Review.

PMID:
28732239
9.
10.

A urinary test procedure for identification of cannabidiol in patients undergoing medical therapy with marijuana.

Wertlake PT, Henson MD.

J Pain Res. 2016 Feb 12;9:81-5. doi: 10.2147/JPR.S96856. eCollection 2016.

11.

Risks associated with the non-medicinal use of cannabis.

Hoch E, Bonnetn U, Thomasius R, Ganzer F, Havemann-Reinecke U, Preuss UW.

Dtsch Arztebl Int. 2015 Apr 17;112(16):271-8. doi: 10.3238/arztebl.2015.0271. Review.

12.

Cannabinoid-Induced Changes in the Activity of Electron Transport Chain Complexes of Brain Mitochondria.

Singh N, Hroudová J, Fišar Z.

J Mol Neurosci. 2015 Aug;56(4):926-931. doi: 10.1007/s12031-015-0545-2. Epub 2015 Mar 29.

PMID:
25820672
13.

Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans.

Manini AF, Yiannoulos G, Bergamaschi MM, Hernandez S, Olmedo R, Barnes AJ, Winkel G, Sinha R, Jutras-Aswad D, Huestis MA, Hurd YL.

J Addict Med. 2015 May-Jun;9(3):204-10. doi: 10.1097/ADM.0000000000000118.

14.

The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough.

Makwana R, Venkatasamy R, Spina D, Page C.

J Pharmacol Exp Ther. 2015 Apr;353(1):169-80. doi: 10.1124/jpet.114.221283. Epub 2015 Feb 5.

PMID:
25655949
15.

Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury.

Ribeiro A, Almeida VI, Costola-de-Souza C, Ferraz-de-Paula V, Pinheiro ML, Vitoretti LB, Gimenes-Junior JA, Akamine AT, Crippa JA, Tavares-de-Lima W, Palermo-Neto J.

Immunopharmacol Immunotoxicol. 2015 Feb;37(1):35-41. doi: 10.3109/08923973.2014.976794. Epub 2014 Oct 30.

PMID:
25356537
16.

Cannabinoid-induced changes in respiration of brain mitochondria.

Fišar Z, Singh N, Hroudová J.

Toxicol Lett. 2014 Nov 18;231(1):62-71. doi: 10.1016/j.toxlet.2014.09.002. Epub 2014 Sep 6.

PMID:
25195527
17.

Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.

Moldzio R, Pacher T, Krewenka C, Kranner B, Novak J, Duvigneau JC, Rausch WD.

Phytomedicine. 2012 Jun 15;19(8-9):819-24. doi: 10.1016/j.phymed.2012.04.002. Epub 2012 May 7.

PMID:
22571976
18.

Cannabinoid effects on ventilation and breathlessness: a pilot study of efficacy and safety.

Pickering EE, Semple SJ, Nazir MS, Murphy K, Snow TM, Cummin AR, Moosavi SH, Guz A, Holdcroft A.

Chron Respir Dis. 2011;8(2):109-18. doi: 10.1177/1479972310391283. Epub 2011 Mar 24.

PMID:
21436223
19.

Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats.

McQueen DS, Bond SM, Smith PJ, Balali-Mood K, Smart D.

Eur J Pharmacol. 2004 May 3;491(2-3):181-9.

PMID:
15140635
20.

Medicinal use of cannabis: history and current status.

Kalant H.

Pain Res Manag. 2001 Summer;6(2):80-91.

PMID:
11854770

Supplemental Content

Loading ...
Support Center